Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
MKC8866 inhibits IRE1 RNase in breast cancer cells leading to the decreased production of pro-tumorigenic factors and it can inhibits prostate cancer (PCa) tumor growth
3-dihydroxypropoxy)-5-(2-methoxyphenoxy)-2-(4-methoxyphenyl)pyrimidin-4-yl)benzenesulfonamide
InChiKey: HMSFWLUZEDMXMM-UHFFFAOYSA-N
InChiKey: OENHQHLEOONYIE-BVZAMQQESA-N
(±)-J 113397 imebutine maleate MKC8866 inhibits IRE1 RNase in() J 113397 is a potent and selective non peptidyl antagonist of ORL1 receptor, with a Ki value of 1. 8 nM for cloned human ORL1 . The ORL1 receptor is a G protein coupled. It is structurally related to the opioid receptors. The heptadecapeptide nociceptin orphanin FQ is the endogenous ligand . In CHO ORL1 cells, nociceptinr orphanin FQ dose dependently suppressed the accumulation of cyclic AMP stimulated by forskolin with an EC value of 0. 22 0. 011
US$ 185.50
US$ 693.00
US$ 143.00
US$ 299.50
US$ 636.00
US$ 336.00
US$ 474.00
US$ 139.00
US$ 249.00
US$ 301.00
US$ 213.50